Accumulation of CCR4 + CTLA-4 hi FOXP3 +CD25 hi regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Svensson, Helena ^a   Olofsson, Veronica ^a   Lundin, Samuel ^a   Yakkala, Chakradhar ^a   Björck, Stellan ^a   Börjesson, Lars ^a   Gustavsson, Bengt ^a   Quiding Järbrink, Marianne ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; TRANSCRIPTION FACTOR FOXP3; CCR4 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA;

ARTICLE; CD25+ T LYMPHOCYTE; CELL ACTIVITY; CELL INFILTRATION; CELL ISOLATION; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON RESECTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEMETHYLATION; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; LYMPHOCYTE HOMING; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ADENOCARCINOMA; COLLOID CARCINOMA; COLON TUMOR; IMMUNITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MUCOSA; T LYMPHOCYTE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; COLONIC NEOPLASMS; CTLA-4 ANTIGEN; HUMANS; IMMUNITY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MUCOUS MEMBRANE; RECEPTORS, CCR4; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84856471270     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030695     Document Type: Article

References (49)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, et al. (2005) Colorectal cancer. Lancet 365: 153-165.
2. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, et al. (1998) The central role of CD4(+) T cells in the antitumor immune response. J Exp Med 188: 2357-2368.
3. Springer TA, (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
4. Marelli-Berg FM, Cannella L, Dazzi F, Mirenda V, (2008) The highway code of T cell trafficking. J Pathol 214: 179-189.
5. Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, et al. (1993) Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74: 185-195.
6. Michie SA, Streeter PR, Bolt PA, Butcher EC, Picker LJ, (1993) The human peripheral lymph node vascular addressin. An inducible endothelial antigen involved in lymphocyte homing. Am J Pathol 143: 1688-1698.
7. Sallusto F, Mackay CR, Lanzavecchia A, (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18: 593-620.
8. Malmberg KJ, (2004) Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape? Cancer Immunol Immunother 53: 879-892.
9. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949.
10. Hiraoka N, Onozato K, Kosuge T, Hirohashi S, (2006) Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12: 5423-5434.
11. Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, et al. (2007) FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 13: 902-911.
12. Sakaguchi S, (2008) Regulatory T cells in the past and for the future. Eur J Immunol 38: 901-937.
13. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, et al. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
14. Cao X, Cai SF, Fehniger TA, Song J, Collins LI, et al. (2007) Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27: 635-646.
15. Ganss R, Arnold B, Hammerling GJ, (2004) Mini-review: overcoming tumor-intrinsic resistance to immune effector function. Eur J Immunol 34: 2635-2641.
16. Ryschich E, Schmidt J, Hammerling GJ, Klar E, Ganss R, (2002) Transformation of the microvascular system during multistage tumorigenesis. Int J Cancer 97: 719-725.
17. Enarsson K, Johnsson E, Lindholm C, Lundgren A, Pan-Hammarstrom Q, et al. (2006) Differential mechanisms for T lymphocyte recruitment in normal and neoplastic human gastric mucosa. Clin Immunol 118: 24-34.
18. Enarsson K, Lundgren A, Kindlund B, Hermansson M, Roncador G, et al. (2006) Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin Immunol 121: 358-368.
19. Salama P, Phillips M, Grieu F, Morris M, Zeps N, et al. (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27: 186-192.
20. Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette MT, et al. (2008) High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 57: 772-779.
21. Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, et al. (2006) CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE 1: e129.
22. Ling KL, Pratap SE, Bates GJ, Singh B, Mortensen NJ, et al. (2007) Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 7: 7.
23. Michel S, Benner A, Tariverdian M, Wentzensen N, Hoefler P, et al. (2008) High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br J Cancer 99: 1867-1873.
24. Bonertz A, Weitz J, Pietsch DH, Rahbari NN, Schlude C, et al. (2009) Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J Clin Invest 119: 3311-3321.
25. Correale P, Rotundo MS, Del Vecchio MT, Remondo C, Migali C, et al. (2010) Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. J Immunother 33: 435-441.
26. Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, et al. (2010) High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 126: 2635-2643.
27. Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, et al. (2010) Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 222: 350-366.
28. Sinicrope FA, Rego RL, Ansell SM, Knutson KL, Foster NR, et al. (2009) Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology 137: 1270-1279.
29. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
30. Sansom DM, Walker LS, (2006) The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev 212: 131-148.
31. Agace WW, Higgins JM, Sadasivan B, Brenner MB, Parker CM, (2000) T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines. Curr Opin Cell Biol 12: 563-568.
32. Siewert C, Lauer U, Cording S, Bopp T, Schmitt E, et al. (2008) Experience-driven development: effector/memory-like alphaE+Foxp3+ regulatory T cells originate from both naive T cells and naturally occurring naive-like regulatory T cells. J Immunol 180: 146-155.
33. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, et al. (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187: 129-134.
34. Han Y, Guo Q, Zhang M, Chen Z, Cao X, (2009) CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J Immunol 182: 111-120.
35. Anz D, Mueller W, Golic M, Kunz WG, Rapp M, et al. (2011) CD103 is a hallmark of tumor-infiltrating regulatory T cells. Int J Cancer.
36. Jass JR, (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50: 113-130.
37. Suzuki H, Chikazawa N, Tasaka T, Wada J, Yamasaki A, et al. (2010) Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer. Cancer Immunol Immunother 59: 653-661.
38. Shen Z, Zhou S, Wang Y, Li RL, Zhong C, et al. (2010) Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol 136: 1585-1595.
39. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, et al. (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964.
40. Shibahara T, Wilcox JN, Couse T, Madara JL, (2001) Characterization of epithelial chemoattractants for human intestinal intraepithelial lymphocytes. Gastroenterology 120: 60-70.
41. Ren Z, Pang G, Clancy R, Li LC, Lee CS, et al. (2001) Shift of the gastric T-cell response in gastric carcinoma. J Gastroenterol Hepatol 16: 142-148.
42. Yoon SH, Yun SO, Park JY, Won HY, Kim EK, et al. (2009) Selective addition of CXCR3(+) CCR4(-) CD4(+) Th1 cells enhances generation of cytotoxic T cells by dendritic cells in vitro. Exp Mol Med 41: 161-170.
43. Christensen JE, de Lemos C, Moos T, Christensen JP, Thomsen AR, (2006) CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J Immunol 176: 4235-4243.
44. Mohan K, Cordeiro E, Vaci M, McMaster C, Issekutz TB, (2005) CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets. Eur J Immunol 35: 1702-1711.
45. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, et al. (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194: 847-853.
46. Lundgren A, Stromberg E, Sjoling A, Lindholm C, Enarsson K, et al. (2005) Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 73: 523-531.
47. Roncador G, Brown PJ, Maestre L, Hue S, Martinez-Torrecuadrada JL, et al. (2005) Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 35: 1681-1691.
48. Janson PC, Linton LB, Bergman EA, Marits P, Eberhardson M, et al. (2011) Profiling of CD4+ T cells with epigenetic immune lineage analysis. J Immunol 186: 92-102.
49. Bergquist C, Mattsson-Rydberg A, Lonroth H, Svennerholm A, (2000) Development of a new method for the determination of immune responses in the human stomach. J Immunol Methods 234: 51-59.